Toggle Main Menu Toggle Search

Open Access padlockePrints

Ex vivo T-lymphopoiesis assays assisting corrective treatment choice for genetically undefined T-lymphocytopenia

Lookup NU author(s): Professor Andrew GenneryORCiD, Professor Sophie HambletonORCiD, Dr Zohreh Nademi

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2025 The Authors. Persistent selective T-lymphocytopenia is found both in SCID and congenital athymia. Without molecular diagnosis, it is challenging to determine whether HCT or thymus transplantation ought to be performed. Ex vivo T-lymphopoiesis assays have been proposed to assist clinical decision-making for genetically undefined patients. We investigated 20 T-lymphocytopenic patients, including 13 patients awaiting first-line treatment and 7 patients with failed immune reconstitution after previous HCT or thymus transplantation. Whilst developmental blocks in ex vivo T-lymphopoiesis indicated hematopoietic cell-intrinsic defects, successful T-lymphocyte differentiation required careful interpretation, in conjunction with clinical status, immunophenotyping, and genetic investigations. Of the 20 patients, 13 proceeded to treatment, with successful immune reconstitution observed in 4 of the 6 patients post-HCT and 4 of the 7 patients after thymus transplantation, the latter including two patients who had previously undergone HCT. Whilst further validation and standardization are required, we conclude that assessing ex vivo T-lymphopoiesis during the diagnostic pathway for genetically undefined T-lymphocytopenia improves patient outcomes by facilitating corrective treatment choice.


Publication metadata

Author(s): Golwala ZM, Spiridou Goncalves H, Moirangthem RD, Evans G, Lizot S, de Koning C, Garrigue A, Corredera MM, Ocampo-Godinez JM, Howley E, Kricke S, Awuah A, Obiri-Yeboa I, Rai R, Sebire N, Bernard F, Bordon Cueto De Braem V, Boztug K, Cole T, Gennery AR, Hackett S, Hambleton S, Holm M, Kusters MA, Klocperk A, Marzollo A, Marcus N, Nademi Z, Pachlopnik Schmid J, Pichler H, Sellmer A, Soler-Palacin P, Soomann M, Torpiano P, van Montfrans J, Nierkens S, Adams S, Buckland M, Gilmour K, Worth A, Thrasher AJ, Davies EG, Andre I, Kreins AY

Publication type: Article

Publication status: Published

Journal: Clinical Immunology

Year: 2025

Volume: 274

Print publication date: 01/05/2025

Online publication date: 16/02/2025

Acceptance date: 10/02/2025

Date deposited: 10/03/2025

ISSN (print): 1521-6616

ISSN (electronic): 1521-7035

Publisher: Academic Press Inc.

URL: https://doi.org/10.1016/j.clim.2025.110453

DOI: 10.1016/j.clim.2025.110453

Data Access Statement: Data will be made available on request.


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Czech Health Research Council and Ministry of Health, Czech Republic.
GOSH Biomedical Research Centre (BRC)
GOSH is supported by the National Institute of Health Research (NIHR)
GOSH Children’s Charity
Swiss National Science Foundation (320030_205097)
UK Medical Research Council (MR/Y013395/1)
Wellcome Trust (RR: 104807/Z/14/Z; AJT: 217112/Z/ 19/Z; AYK: 222096/Z/20/Z)

Share